SseL Deubiquitinates RPS3 to Inhibit Its Nuclear Translocation

• Published in: Pathogens (Basel) Vol. 7; no. 4; p. 86
• Main Authors: Wu, Miaomiao, El Qaidi, Samir, Hardwidge, Philip R
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 07-11-2018; MDPI
• Subjects: Bacterial diseases; Cytoplasm; DNA repair; E coli; effector; Effectors; Experiments; Gene expression; Gram-negative bacteria; Innate immunity; Kinases; NF-κB protein; nuclear translocation; Nuclear transport; Pathogens; Phosphorylation; Proteins; Proteolysis; Quality control; Ribosomal protein S3; RSP3; Salmonella; SseL; Transcription activation; Translocation; Tumor necrosis factor-TNF; ubiquitination; Virulence; SseL; RSP3; effector; nuclear translocation; ubiquitination
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens7040086

Many Gram-negative bacterial pathogens use type III secretion systems to deliver virulence proteins (effectors) into host cells to counteract innate immunity. The ribosomal protein S3 (RPS3) guides NF-κB subunits to specific κB sites and plays an important role in the innate response to bacterial infection. Two
effectors inhibit RPS3 nuclear translocation. NleH1 inhibits RPS3 phosphorylation by IKK-β, an essential aspect of the RPS3 nuclear translocation process. NleC proteolysis of p65 generates an N-terminal p65 fragment that competes for full-length p65 binding to RPS3, thus also inhibiting RPS3 nuclear translocation. Thus,
has multiple mechanisms by which to block RPS3-mediated transcriptional activation. With this in mind, we considered whether other enteric pathogens also encode T3SS effectors that impact this important host regulatory pathway. Here we report that the
Secreted Effector L (SseL), which was previously shown to function as a deubiquitinase and inhibit NF-κB signaling, also inhibits RPS3 nuclear translocation by deubiquitinating this important host transcriptional co-factor. RPS3 deubiquitination by SseL was restricted to K63-linkages and mutating the active-site cysteine of SseL abolished its ability to deubiquitinate and subsequently inhibit RPS3 nuclear translocation. Thus,
also encodes at least one T3SS effector that alters RPS3 activities in the host nucleus.